CA Stock MarketDetailed Quotes

ONC Oncolytics Biotech Inc

Watchlist
  • 1.180
  • -0.020-1.67%
15min DelayMarket Closed Dec 13 16:00 ET
90.95MMarket Cap-3.28P/E (TTM)

About Oncolytics Biotech Inc Company

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.

Company Profile

SymbolONC
Company NameOncolytics Biotech Inc
Founded1998
MarketTSE
Employees27
Fiscal Year Ends12-31
Address322 11th Avenue S.W Suite 804
CityCalgary
CountryCAN
Zip CodeT2R 0C5
Phone+1 403 670-7377

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Matthew C. Coffey,PhD
  • President, Chief Executive Officer and Director
  • 2.25M
  • Dr. Thomas C. Heineman, M.D.
  • Chief Medical Officer
  • 1.36M
  • Kirk J. Look
  • Chief Financial Officer
  • 1.32M
  • Amy G. Levin
  • Vice President, Clinical Operations
  • 683.55K
  • Allison Hagerman, P. Eng.
  • Vice President, Product Development
  • 727.64K
  • Wayne Pisano
  • Chairman of the Board
  • 165.01K
  • Patricia S. Andrews
  • Director
  • --
  • Jonathan M. Rigby
  • Independent Director
  • 107.40K
  • James T. Parsons
  • Independent Director
  • 116.36K
  • Angela Holtham
  • Independent Director
  • 130.58K
  • Dr. Bernd R. Seizinger, M.D.,PhD
  • Independent Director
  • 123.96K
  • Deborah M. Brown
  • Independent Director
  • 124.95K